0 results for 'Wyeth'
Litigator of the Week Runners-Up and Shout-Outs
A team at Covington & Burling knocked out a $107.5 million patent infringement verdict facing pharmaceutical client AstraZeneca.Covington Defeats Jones Day: AstraZeneca Escapes $107.5M Verdict
AstraZeneca prevailed on its argument that patents-in-suit are invalid because they are not enabled on the issue of unit dosage.Balancing Act: Some GCs Are Embracing the Dual Role of COO
Initialized Capital, a seed-stage venture capital firm managing over $3 billion in assets, is the latest company to embrace this trend by promoting Livingston Miller, its general counsel, to the position of COO.Artists Sue SEC in Preemptive Lawsuit Over Whether NFTs Are Securities
"The SEC has gone beyond what people traditionally think of as investment contracts or securities, and they have now started encroaching into the art world, just because the art in their previous cases happened to be digital," Jason Gottlieb, a partner at Morrison Cohen, said in an interview.Federal Circuit To Decide Constitutionality of 'Bad Faith' Patent Litigation Statutes
On May 3, 2023, Judge David C. Nye of the District of Idaho imposed the first-ever bond order under Idaho's Bad Faith Assertions of Patent Infringement Act. In that order, the court required patent owner Katana or its parent company, Longhorn, to post an $8 million bond before allowing it to proceed with its patent infringement suit against Micron.View more book results for the query "Wyeth"
New Jersey Pursues Wyeth, a Pfizer Subsidiary, Over Chemical Disposal
The property was used for manufacturing of drugs and chemicals from 1915 to 1999, the suit states. During that period, waste was placed in at least 27 large, pondlike storage and disposal areas that were referred to as impoundments, the suit claims.Too Good to Be True? Ozempic Lawsuit Moves Forward as Gastrointestinal Issues Surface
Ozempic isn't without side effects, however, and several patients who have experienced severe complications from the drug are now suing Novo Nordisk and Eli Lilly on allegations that the pharmaceutical companies misled doctors on the drugs' potential risks.Warning: Your Opening Statement or Closing Argument May Be Used Against You
The question lawyers need to ponder—and adversaries need to pounce upon—is whether that same admonition applies to what lawyers say in their openings and closings, with the added concern that the warning will be anything you say SHALL be used against you, and you can't dispute it.Remember Fen-phen? Litigation Still Pending Over Lawyer's Expenses
Fleming wants the high court to agree that a take-nothing verdict in his firm's favor in a 2016 trial, Harpst v. Fleming, be binding on the 8,000 plaintiffs in Wilson v. Flemming, his brief on the merits states.Federal Judge Dismisses Suit Alleging Legal Team Misled Plaintiff in Wage-and-Hour Suit vs. Wyeth
A Massachusetts federal judge has agreed to dismiss Pfizer and the plaintiff's former attorneys in the matter of a former Wyeth Pharmaceuticals employee who alleged his legal team misled him at various points during a wage-and-hour suit against his employer.Trending Stories
2024 Trends Report Mid-Year Special Edition: Update on Outside Counsel Billing Rates
Brought to you by LexisNexis® CounselLink®
Download Now
AI in Private Equity: A Guide for Gaining an Early Advantage
Brought to you by Ontra
Download Now
Why Are So Many Law Firms Suddenly Embracing Digital Transformation?
Brought to you by AllRize
Download Now
2025 State Legislative Sessions
Brought to you by LexisNexis®
Download Now